Literature DB >> 21943374

Iron-mediated retinal degeneration in haemojuvelin-knockout mice.

Jaya P Gnana-Prakasam1, Amany Tawfik, Michelle Romej, Sudha Ananth, Pamela M Martin, Sylvia B Smith, Vadivel Ganapathy.   

Abstract

Haemochromatosis is a genetic disorder of iron overload resulting from loss-of-function mutations in genes coding for the iron-regulatory proteins HFE (human leucocyte antigen-like protein involved in iron homoeostasis), transferrin receptor 2, ferroportin, hepcidin and HJV (haemojuvelin). Recent studies have established the expression of all of the five genes in the retina, indicating their importance in retinal iron homoeostasis. Previously, we demonstrated that HJV is expressed in RPE (retinal pigment epithelium), the outer and inner nuclear layers and the ganglion cell layer. In the present paper, we report on the consequences of Hjv deletion on the retina in mice. Hjv-/- mice at ≥18 months of age had increased iron accumulation in the retina with marked morphological damage compared with age-matched controls; these changes were not found in younger mice. The retinal phenotype in Hjv-/- mice included hyperplasia of RPE. We isolated RPE cells from wild-type and Hjv-/- mice and examined their growth patterns. Hjv-/- RPE cells were less senescent and exhibited a hyperproliferative phenotype. Hjv-/- RPE cells also showed up-regulation of Slc7a11 (solute carrier family 7 member 11 gene), which encodes the 'transporter proper' subunit xCT in the heterodimeric amino acid transporter xCT/4F2hc (cystine/glutamate exchanger). BMP6 (bone morphogenetic protein 6) could not induce hepcidin expression in Hjv-/- RPE cells, confirming that retinal cells require HJV for induction of hepcidin via BMP6 signalling. HJV is a glycosylphosphatidylinositol-anchored protein, and the membrane-associated HJV is necessary for BMP6-mediated activation of hepcidin promoter in RPE cells. Taken together, these results confirm the biological importance of HJV in the regulation of iron homoeostasis in the retina and in RPE.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21943374      PMCID: PMC3710445          DOI: 10.1042/BJ20111148

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

Review 1.  Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies.

Authors:  Jayakrishna Ambati; Balamurali K Ambati; Sonia H Yoo; Sean Ianchulev; Anthony P Adamis
Journal:  Surv Ophthalmol       Date:  2003 May-Jun       Impact factor: 6.048

2.  The Bowman lecture. Towards an understanding of age-related macular disease.

Authors:  A C Bird
Journal:  Eye (Lond)       Date:  2003-05       Impact factor: 3.775

3.  Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane.

Authors:  Paul Hahn; Ann H Milam; Joshua L Dunaief
Journal:  Arch Ophthalmol       Date:  2003-08

4.  Ocular pathologic changes in primary hemochromatosis.

Authors:  A M Roth; R Y Foos
Journal:  Arch Ophthalmol       Date:  1972-05

5.  Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells.

Authors:  C C Bridges; R Kekuda; H Wang; P D Prasad; P Mehta; W Huang; S B Smith; V Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-01       Impact factor: 4.799

6.  The basal ganglia in haemochromatosis.

Authors:  D Berg; U Hoggenmüller; E Hofmann; R Fischer; M Kraus; M Scheurlen; G Becker
Journal:  Neuroradiology       Date:  2000-01       Impact factor: 2.804

7.  Induction of cystine-glutamate transporter xc- by human immunodeficiency virus type 1 transactivator protein tat in retinal pigment epithelium.

Authors:  Christy C Bridges; Huankai Hu; Seiji Miyauchi; Umapathy N Siddaramappa; Malliga E Ganapathy; Leszek Ignatowicz; Dennis M Maddox; Sylvia B Smith; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

8.  Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina.

Authors:  Paul Hahn; Tzvete Dentchev; Ying Qian; Tracey Rouault; Z Leah Harris; Joshua L Dunaief
Journal:  Mol Vis       Date:  2004-08-26       Impact factor: 2.367

9.  Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration.

Authors:  Paul Hahn; Ying Qian; Tzvete Dentchev; Lin Chen; John Beard; Zena Leah Harris; Joshua L Dunaief
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

10.  Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series.

Authors:  D J Costello; S L Walsh; H J Harrington; C H Walsh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

View more
  22 in total

1.  CD1 Mouse Retina Is Shielded From Iron Overload Caused by a High Iron Diet.

Authors:  Devang L Bhoiwala; Ying Song; Alyssa Cwanger; Esther Clark; Liang-liang Zhao; Chenguang Wang; Yafeng Li; Delu Song; Joshua L Dunaief
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

2.  Ferroportin-mediated iron export from vascular endothelial cells in retina and brain.

Authors:  Bailey H Baumann; Wanting Shu; Ying Song; Elizabeth M Simpson; Samira Lakhal-Littleton; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2019-07-16       Impact factor: 3.467

3.  Microarray analysis of murine retinal light damage reveals changes in iron regulatory, complement, and antioxidant genes in the neurosensory retina and isolated RPE.

Authors:  Majda Hadziahmetovic; Usha Kumar; Ying Song; Steven Grieco; Delu Song; Yafeng Li; John W Tobias; Joshua L Dunaief
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-07       Impact factor: 4.799

4.  Polarized distribution of heme transporters in retinal pigment epithelium and their regulation in the iron-overload disease hemochromatosis.

Authors:  Jaya P Gnana-Prakasam; Sushma K Reddy; Rajalakshmi Veeranan-Karmegam; Sylvia B Smith; Pamela M Martin; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

5.  Loss of Hfe leads to progression of tumor phenotype in primary retinal pigment epithelial cells.

Authors:  Jaya P Gnana-Prakasam; Rajalakshmi Veeranan-Karmegam; Veena Coothankandaswamy; Sushma K Reddy; Pamela M Martin; Muthusamy Thangaraju; Sylvia B Smith; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

6.  Iron Toxicity in the Retina Requires Alu RNA and the NLRP3 Inflammasome.

Authors:  Bradley D Gelfand; Charles B Wright; Younghee Kim; Tetsuhiro Yasuma; Reo Yasuma; Shengjian Li; Benjamin J Fowler; Ana Bastos-Carvalho; Nagaraj Kerur; Annette Uittenbogaard; Youn Seon Han; Dingyuan Lou; Mark E Kleinman; W Hayes McDonald; Gabriel Núñez; Philippe Georgel; Joshua L Dunaief; Jayakrishna Ambati
Journal:  Cell Rep       Date:  2015-06-11       Impact factor: 9.423

7.  Deletion of hemojuvelin, an iron-regulatory protein, in mice results in abnormal angiogenesis and vasculogenesis in retina along with reactive gliosis.

Authors:  Amany Tawfik; Jaya P Gnana-Prakasam; Sylvia B Smith; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-08       Impact factor: 4.799

8.  AMD-like retinopathy associated with intravenous iron.

Authors:  Delu Song; Levi N Kanu; Yafeng Li; Kristen L Kelly; Rupak K Bhuyan; Tomas Aleman; Jessica I W Morgan; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2016-08-23       Impact factor: 3.467

9.  Regulation of the cholesterol efflux transporters ABCA1 and ABCG1 in retina in hemochromatosis and by the endogenous siderophore 2,5-dihydroxybenzoic acid.

Authors:  Sudha Ananth; Jaya P Gnana-Prakasam; Yangzom D Bhutia; Rajalakshmi Veeranan-Karmegam; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochim Biophys Acta       Date:  2014-01-23

10.  Retinal iron homeostasis in health and disease.

Authors:  Delu Song; Joshua L Dunaief
Journal:  Front Aging Neurosci       Date:  2013-06-28       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.